The global Alpha-1 Lung Disease Market is estimated to be valued at US$ 4.99 billion in 2023 and is expected to exhibit a CAGR of 18.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview: Alpha-1 lung disease refers to a genetic disorder that causes lung and liver damage. It is characterized by the deficiency of alpha-1 antitrypsin (AAT) protein, which in turn leads to the destruction of lung ... Read more

Alpha 1 lung disease is a genetic disorder that causes damage to the lungs over time. It can cause chronic lung disease in both children and adults. The condition destroys the elastic tissue in the lungs and digestive system, which makes it difficult to breathe over time and can ultimately lead to liver disease and lung failure.

The Alpha 1 lung disease market comprises products used for the treatment of genetic conditions that cause lung and liver damage such as alpha-1 ... Read more